FDA Inspection
Dompe Farmaceutici S.p.A.Dompe Farmaceutici S.p.A. – FDA Inspection, Apr 24, 2018
Record Details
This FDA Inspection record concerns Dompe Farmaceutici S.p.A., with an inspection on April 24, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Maxwell L. Van Tassell (Issuing Officer)
- Wayne E. Seifert (Senior Regulatory Specialist)
View Company Profile
ID · 3918686f-d89f-41e9-8ce2-e5fa3c40a748
Inspection Facts
- Inspection number
- 1055762
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Dompe Farmaceutici S.p.A.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dompe Farmaceutici S.p.A.
- FDA Inspection 1286070 - 2022-09-20
- FDA Inspection 1121884 - 2020-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.